Earningsreport

Q2/2024 6/30/2024 EPS -0.390 ZacksConsensus -0.410 ActVsEst 0.020 - Beat

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations